Key references: Blood pressure reduction for patients with diabetes
National evidence-based guideline on secondary prevention of cardiovascular disease in type 2 diabetes (part of the guidelines on management of type 2 diabetes). Melbourne: NHMRC; 2015.https://www.baker.edu.au/impact/guidelines
Bakris GL, Sarafidis PA, Weir MR, Dahlof B, Pitt B, Jamerson K, et al. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial. Lancet 2010;375(9721):1173-81.https://www.ncbi.nlm.nih.gov/pubmed/20170948
Chadban S, Howell M, Twigg S, Thomas M, Jerums G, Cass A, et al. The CARI guidelines. Prevention and management of chronic kidney disease in type 2 diabetes. Nephrology (Carlton) 2010;15 Suppl 1:S162-94.https://www.ncbi.nlm.nih.gov/pubmed/20591029
Diabetes Canada Clinical Practice Guidelines Expert C, Tobe SW, Gilbert RE, Jones C, Leiter LA, Prebtani APH, et al. Treatment of hypertension. Can J Diabetes 2018;42 Suppl 1:S186-S9.https://www.ncbi.nlm.nih.gov/pubmed/29650094
Jamerson K, Weber MA, Bakris GL, Dahlof B, Pitt B, Shi V, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008;359(23):2417-28.https://www.ncbi.nlm.nih.gov/pubmed/19052124
